🇺🇸 FDA
Patent

US 10507284

Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type I diabetes applications

granted A61PA61P3/10

Quick answer

US patent 10507284 (Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type I diabetes applications) held by The Regents of the University of California expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P3/10